Health Care
Commentary
A Bipartisan Regulatory Reform Opportunity: 340B
Despite the rancor, there are many bipartisan opportunities for the divided 118th Congress. Near the top of the to-do list should be reforming the well-intentioned, but poorly designed, 340B drug discount program. 340B enables qualifying institutions to purchase medicines from manufacturers at steep discounts, generally between 25% and 50% off list ...
Blog
Key Takeaways from President Biden’s Proposed 2024 Healthcare Budget
The United States currently faces a deficit of over $700 billion. Not including other health programs, in 2021, over $734 billion was spent on Medicaid alone. Despite these facts, President Biden’s 2024 budget proposal aims to increase funding for healthcare by 11.5%. The proposal claims proposed tax increases will not ...
Commentary
Sanders’ Haughty Stance Against Medical Innovators Harms Lives
Sen. Bernie Sanders, I-Vt., has summoned Moderna CEO Stéphane Bancel to Capitol Hill for a public chastising next week. The hearing will probe why the biotech firm would consider raising the price of its COVID-19 vaccine. Since the federal government played some role in the vaccine’s development, Sen. Sanders argues, it ...
Commentary
Blame the Affordable Care Act for rising health care costs
More than half of Americans today rate the quality of U.S. health care as subpar, according to a new Gallup poll. More than 1 in 5 call it “poor.” That represents a remarkable reversal in public opinion. Just 10 years ago, nearly two-thirds of Americans praised the quality of care. Perhaps ...
Commentary
Hospitals aren’t being honest about costs, and we’re paying the price
Imagine receiving a bill for $10,000. It’s from your local hospital, where you had a minor procedure. But you have no idea why it’s so high, or how you’re going to pay. If you’ve ever had an experience like this, you’re not alone. In 2020, a California couple was billed ...
Commentary
Don’t fund Medicare with higher taxes
President Joe Biden recently released his budget proposal for 2024. His plan pledges to extend Medicare’s solvency by at least 25 years “without cutting any benefits or raising costs for beneficiaries.” The president’s math doesn’t add up. His plan would burden taxpayers while leaving Medicare on the fast track to insolvency. Medicare’s Part A ...
Commentary
Bernie Doesn’t “Get” Healthcare Innovation
Next week, Moderna CEO Stéphane Bancel will testify before the Senate Health, Education, Labor, and Pensions Committee on the price of his company’s COVID-19 vaccine. He’ll face an unfriendly audience. Committee Chairman Sen. Bernie Sanders, I-Vt., claims that companies like Moderna profited off COVID at Americans’ expense. He’s eager to “rein in the greed ...
Commentary
Time to drag hospital pricing out of the shadows
It’s been more than two years since a rule promulgated during the Trump administration requiring hospitals to disclose their prices took effect. Yet according to a new study, most hospitals aren’t complying. The analysis, published in January in the Journal of General Internal Medicine, found that just 19% of hospitals examined fully ...
Commentary
Britain Desperately Needs More Private Healthcare Options
Consultants at the British Medical Association are threatening to go on strike, citing pay cuts. They’d be joining a months-long series of walkouts by British medical staffers. Nurses with the country’s government-run National Health Service took to the picket lines in mid-December, January, and February. And while the British government plans to discuss ...
Commentary
How The Republican House Can Prevent Medicare Price Controls From Becoming Death Sentences
The Inflation Reduction Act’s (IRA) drug pricing provisions will severely curtail life-science research. The IRA vests the Centers for Medicare & Medicaid Services with the power to impose price controls on an ever-expanding list of drugs. The direct result will be that seniors today — as well as future generations ...
A Bipartisan Regulatory Reform Opportunity: 340B
Despite the rancor, there are many bipartisan opportunities for the divided 118th Congress. Near the top of the to-do list should be reforming the well-intentioned, but poorly designed, 340B drug discount program. 340B enables qualifying institutions to purchase medicines from manufacturers at steep discounts, generally between 25% and 50% off list ...
Key Takeaways from President Biden’s Proposed 2024 Healthcare Budget
The United States currently faces a deficit of over $700 billion. Not including other health programs, in 2021, over $734 billion was spent on Medicaid alone. Despite these facts, President Biden’s 2024 budget proposal aims to increase funding for healthcare by 11.5%. The proposal claims proposed tax increases will not ...
Sanders’ Haughty Stance Against Medical Innovators Harms Lives
Sen. Bernie Sanders, I-Vt., has summoned Moderna CEO Stéphane Bancel to Capitol Hill for a public chastising next week. The hearing will probe why the biotech firm would consider raising the price of its COVID-19 vaccine. Since the federal government played some role in the vaccine’s development, Sen. Sanders argues, it ...
Blame the Affordable Care Act for rising health care costs
More than half of Americans today rate the quality of U.S. health care as subpar, according to a new Gallup poll. More than 1 in 5 call it “poor.” That represents a remarkable reversal in public opinion. Just 10 years ago, nearly two-thirds of Americans praised the quality of care. Perhaps ...
Hospitals aren’t being honest about costs, and we’re paying the price
Imagine receiving a bill for $10,000. It’s from your local hospital, where you had a minor procedure. But you have no idea why it’s so high, or how you’re going to pay. If you’ve ever had an experience like this, you’re not alone. In 2020, a California couple was billed ...
Don’t fund Medicare with higher taxes
President Joe Biden recently released his budget proposal for 2024. His plan pledges to extend Medicare’s solvency by at least 25 years “without cutting any benefits or raising costs for beneficiaries.” The president’s math doesn’t add up. His plan would burden taxpayers while leaving Medicare on the fast track to insolvency. Medicare’s Part A ...
Bernie Doesn’t “Get” Healthcare Innovation
Next week, Moderna CEO Stéphane Bancel will testify before the Senate Health, Education, Labor, and Pensions Committee on the price of his company’s COVID-19 vaccine. He’ll face an unfriendly audience. Committee Chairman Sen. Bernie Sanders, I-Vt., claims that companies like Moderna profited off COVID at Americans’ expense. He’s eager to “rein in the greed ...
Time to drag hospital pricing out of the shadows
It’s been more than two years since a rule promulgated during the Trump administration requiring hospitals to disclose their prices took effect. Yet according to a new study, most hospitals aren’t complying. The analysis, published in January in the Journal of General Internal Medicine, found that just 19% of hospitals examined fully ...
Britain Desperately Needs More Private Healthcare Options
Consultants at the British Medical Association are threatening to go on strike, citing pay cuts. They’d be joining a months-long series of walkouts by British medical staffers. Nurses with the country’s government-run National Health Service took to the picket lines in mid-December, January, and February. And while the British government plans to discuss ...
How The Republican House Can Prevent Medicare Price Controls From Becoming Death Sentences
The Inflation Reduction Act’s (IRA) drug pricing provisions will severely curtail life-science research. The IRA vests the Centers for Medicare & Medicaid Services with the power to impose price controls on an ever-expanding list of drugs. The direct result will be that seniors today — as well as future generations ...
